TY  - JOUR

T1  - 305-OR: Tirzepatide in Type 1 Diabetes—Safety, Tolerability, and Clinical Outcomes—Real-World Experience from a Large UK Center

JO  - Diabetes

UR  - https://doi.org/10.2337/db25-305-or

PY  - 2025/06/20

AU  - BERRY SA

AU  - MCNALLY E

AU  - GOODMAN I

AU  - ELLIOTT J

AU  - IQBAL A

ED  - 

DO  - DOI: 10.2337/db25-305-or

PB  - American Diabetes Association

VL  - 74

IS  - Supplement_1

Y2  - 2025/06/24

ER  -